Effects of morphine-3-glucuronide and morphine on the K+-evoked release of [3H]-glutamic acid and [14C]-gamma-aminobutyric acid from rat brain synaptosomes

This publication has 17 references indexed in Scilit:

• Pharmacology of Morphine and Morphine‐3‐glucuronide at Opioid, Excitatory Amino Acid, GABA and Glycine Binding Sites
  Basic & Clinical Pharmacology & Toxicology, 1994
• The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex
  Life Sciences, 1994
• Depolarization by K+ and glutamate activates different neurotransmitter release mechanisms in gabaergic neurons: Vesicular versus non-vesicular release of GABA
  Neuroscience, 1993
• Modulation of GABA release by α-amino-3-hydroxy-5-methylisoxazole-4-propionate and N-methyl-d-aspartate receptors in matrix-enriched areas of the rat striatum
  Neuroscience, 1992
• Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord
  Pain, 1990
• Morphine-3-glucuronide - a potent antagonist of morphine analgesia
  Life Sciences, 1990
• IntrathecalN-methyl-d-aspartate (NMDA) activates both nociceptive and antinociceptive systems
  Brain Research, 1987
• High Doses of Spinal Morphine Produce a Nonopiate Receptormediated Hyperesthesia
  Anesthesiology, 1986
• Intrathecal high dose morphine produces hyperalgesia in the rat
  Brain Research, 1981
• Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity
  Brain Research, 1979